Benatti Luca

Insider Reports History

Location
C/O Intercept Pharmaceuticals, Inc., 450 West 15 Th Street, Suite 505, New York, NY
Signature
/s/ Brendan Hannah as attorney-in-fact for Luca Benatti
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benatti Luca:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Director Director Stock Option (Right to Buy) 27K Jun 4, 2025 Direct
Quince Therapeutics, Inc. Director Employee Stock Option (right to buy) 27K Jun 5, 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Benatti Luca

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNCX Quince Therapeutics, Inc. Jun 4, 2025 1 $0 4 Jun 6, 2025 Director
QNCX Quince Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 12 -$638K 4 Nov 13, 2023 Director
QNCX Quince Therapeutics, Inc. Oct 23, 2023 1 $0 4 Oct 24, 2023 Director
QNCX Quince Therapeutics, Inc. Oct 23, 2023 0 $0 3 Oct 24, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director